| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gursharan Singh Samra, Saumitra Kant, Robert Cho. Risperidone induced angioedema with concurrent EPS symptoms: a case report and review of literature. Journal of community hospital internal medicine perspectives. vol 8. issue 2. 2020-10-01. PMID:29686794. |
a 40-year-old male with a history of schizophrenia was started on 3 mg of risperidone bid and developed perioral and periorbital edema along with increased muscle rigidity and hand tremor within 24 h of initial administration. |
2020-10-01 |
2023-08-13 |
Not clear |
| Kotaro Hatta, Naoya Sugiyama, Hiroto It. Switching and augmentation strategies for antipsychotic medications in acute-phase schizophrenia: latest evidence and place in therapy. Therapeutic advances in psychopharmacology. vol 8. issue 6. 2020-10-01. PMID:29854396. |
for risperidone and olanzapine, there is some evidence on switching and augmentation strategies in the management of acute-phase schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Hussam Hindi, James L Lawrenc. Probable Lewy Body Dementia with a Predilection for Auditory Hallucinations. Cureus. vol 10. issue 5. 2020-10-01. PMID:30013866. |
he was diagnosed with nonspecific schizophrenia and treated with risperidone, trazodone, and lithium. |
2020-10-01 |
2023-08-13 |
Not clear |
| Waliul Chowdhury, Muhammad Uzair Lodhi, Aaron R Kuzel, Peter Johnson, Umar Rahim, Mustafa Rahi. Management of Persistent Hyponatremia Induced by Long-acting Injectable Risperidone Therapy. Cureus. vol 10. issue 5. 2020-10-01. PMID:30042908. |
we present the case of a 55-year-old caucasian male with a history of schizophrenia presenting with severe hyponatremia attributed to long-acting injectable risperidone treatment. |
2020-10-01 |
2023-08-13 |
Not clear |
| Peta-Gaye L Thomas-Brown, Jacqueline S Martin, Clayton A Sewell, Wendel D Abel, Maxine D Gossell-William. Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis. Frontiers in pharmacology. vol 9. 2020-10-01. PMID:30072895. |
risperidone provides better improvement of sleep disturbances than haloperidol therapy in schizophrenia patients with cannabis-positive urinalysis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ting-Ren Chen, Ying-Chang Che. Risperidone-Associated Neuroleptic Malignant Syndrome in an Inpatient With Schizophrenia, With Successful Rechallenge and 3 Year Follow-Up. Frontiers in psychiatry. vol 9. 2020-10-01. PMID:30618887. |
a 47-year-old female with schizophrenia was treated with risperidone 4 mg/d for 8 months in 2009 and was admitted to our hospital in 2015 owing to violent behavior under persecutory delusions. |
2020-10-01 |
2023-08-13 |
Not clear |
| Qiongwei Yang, Xiaoyun Guo, Dengtang Li. Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report. Shanghai archives of psychiatry. vol 30. issue 3. 2020-10-01. PMID:30858673. |
hypokalemia caused by quetiapine and risperidone treatment in schizophrenia: a case report. |
2020-10-01 |
2023-08-13 |
Not clear |
| Qiongwei Yang, Xiaoyun Guo, Dengtang Li. Hypokalemia Caused by Quetiapine and Risperidone Treatment in Schizophrenia: A Case Report. Shanghai archives of psychiatry. vol 30. issue 3. 2020-10-01. PMID:30858673. |
we report a 49-year-old female patient with schizophrenia who developed hypokalemia after oral quetiapine and risperidone treatments. |
2020-10-01 |
2023-08-13 |
Not clear |
| Rahul Dhanda, Della Varghese, Vijay R Nadipelli, Maurizio Fava, Namita Joshi, Caitlyn T Solem, James A Graham, Susan M Learned, Christian Heidbrede. Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study. Patient preference and adherence. vol 13. 2020-10-01. PMID:31308636. |
patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study. |
2020-10-01 |
2023-08-13 |
Not clear |
| Rahul Dhanda, Della Varghese, Vijay R Nadipelli, Maurizio Fava, Namita Joshi, Caitlyn T Solem, James A Graham, Susan M Learned, Christian Heidbrede. Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study. Patient preference and adherence. vol 13. 2020-10-01. PMID:31308636. |
rbp-7000 (perseris™) is a once-monthly subcutaneous extended-release risperidone formulation approved by the united states food and drug administration for the treatment of schizophrenia in adults. |
2020-10-01 |
2023-08-13 |
Not clear |
| Novita Linda Akbar, Elmeida Effendy, Vita Camelli. The Indonesian Version of Montreal Cognitive Assessment (MoCA-Ina): The Difference Scores Between Male Schizophrenia Prescribed by Risperidone and Adjunctive of Donepezil in Public Hospital of Dr Pirngadi Medan, Indonesia. Open access Macedonian journal of medical sciences. vol 7. issue 11. 2020-10-01. PMID:31316655. |
the indonesian version of montreal cognitive assessment (moca-ina): the difference scores between male schizophrenia prescribed by risperidone and adjunctive of donepezil in public hospital of dr pirngadi medan, indonesia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Novita Linda Akbar, Elmeida Effendy, Vita Camelli. The Indonesian Version of Montreal Cognitive Assessment (MoCA-Ina): The Difference Scores Between Male Schizophrenia Prescribed by Risperidone and Adjunctive of Donepezil in Public Hospital of Dr Pirngadi Medan, Indonesia. Open access Macedonian journal of medical sciences. vol 7. issue 11. 2020-10-01. PMID:31316655. |
prescribing donepezil as an addition in reducing the cognitive dysfunctions among schizophrenia patients that have been given by antipsychotic (risperidone and olanzapine) is commonly used. |
2020-10-01 |
2023-08-13 |
Not clear |
| Konstantinos N Fountoulakis, Ioannis Nimatoudis, Apostolos Iacovides, George Kaprini. Off-label indications for atypical antipsychotics: A systematic review. Annals of general hospital psychiatry. vol 3. issue 1. 2020-09-30. PMID:14975068. |
material and method: medline was searched with the combination of each one of the key words: risperidone, olanzapine and quetiapine with key words that refered to every dsm-iv diagnosis other than schizophrenia and other psychotic disorders, bipolar disorder and dementia and memory disorders. |
2020-09-30 |
2023-08-12 |
Not clear |
| Vasanth Kattalai Kailasam, Victoria Chima, Uchechukwu Nnamdi, Kavita Sharma, Kairav Sha. Risperidone-induced reversible neutropenia. Neuropsychiatric disease and treatment. vol 13. 2020-09-30. PMID:28794632. |
this case report presents a 44-year-old man with a history of schizophrenia who developed neutropenia on risperidone therapy. |
2020-09-30 |
2023-08-13 |
Not clear |
| Adriano Aquino, Guilherme L Alexandrino, Paul C Guest, Fabio Augusto, Alexandre F Gomes, Michael Murgu, Johann Steiner, Daniel Martins-de-Souz. Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients. Frontiers in psychiatry. vol 9. 2020-09-30. PMID:29887809. |
blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients. |
2020-09-30 |
2023-08-13 |
Not clear |
| Somaye Arabzadeh, Atefeh Zeinoddini, Seyed-Ali Mostafavi, Mehdi Hamedi, Abolfazl Ehyaii, Ali Ghaleiha, Arefeh Zeinoddini, Shahin Akhondzade. Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Iranian journal of psychiatry. vol 13. issue 1. 2020-09-30. PMID:29892311. |
acetaminophen as adjuvant to risperidone in chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial. |
2020-09-30 |
2023-08-13 |
Not clear |
| Sebastian Hörber, Sarah Hudak, Martin Kächele, Dietrich Overkamp, Andreas Fritsche, Hans-Ulrich Häring, Andreas Peter, Martin Hen. Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus Endocrinology, diabetes & metabolism case reports. vol 2018. 2020-09-30. PMID:30306778. |
past history revealed a paranoid schizophrenia diagnosed10 years ago and for which the patient was treated with risperidone for many years. |
2020-09-30 |
2023-08-13 |
Not clear |
| Xiujia Sun, Lihua Wang, Fuzhong Yang, Juanjuan Ren, Ping Jiang, Hongmei Liu, Huafang Li, Chunbo Li, Chen Zhan. Correlation of hair risperidone concentration and serum level among patients with schizophrenia. General psychiatry. vol 32. issue 1. 2020-09-30. PMID:31179425. |
correlation of hair risperidone concentration and serum level among patients with schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Xueping Wang, Yi Su, Hao Yan, Zhuo Huang, Yu Huang, Weihua Yu. Association Study of Frontiers in psychiatry. vol 10. 2020-09-30. PMID:31543842. |
association study of risperidone has been used to treat the symptoms of schizophrenia and to reduce its relapse. |
2020-09-30 |
2023-08-13 |
Not clear |
| Manahap Cerarius F Pardosi, Bahagia Loebis, Muhammad Surya Husada, Nazli M Nasution, Elmeida Effendy, Mustafa M Amin, Vita Camelli. Differences in Total Score of Positive and Negative Syndrome Scale between Bataknese and Javanese Men with Schizophrenia Receiving Risperidone Treatment. Open access Macedonian journal of medical sciences. vol 7. issue 14. 2020-09-30. PMID:31592006. |
differences in total score of positive and negative syndrome scale between bataknese and javanese men with schizophrenia receiving risperidone treatment. |
2020-09-30 |
2023-08-13 |
Not clear |